Evidence map›Paper›PMID 28243057›Full record

ArticleClinical ophthalmology (Auckland, N.Z.)2017

Cost and detection rate of glaucoma screening with imaging devices in a primary care center.

Alfonso Anton, Monica Fallon, Francesc Cots, María A Sebastian, Antonio Morilla-Grasa, Sergi Mojal, Xavier Castells

Open access · goldAbstract read
In one paragraph

Article in Clinical ophthalmology (Auckland, N.Z.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Alfonso AntonMedicine School, Universidad Internacional de Cataluña; Servei d'Estudies, Parc de Salut Mar; Instituto Hospital del Mar de Investigaciones Médicas (IMIM); Glaucoma Department, Instituto Catalán de Retina (ICR).
Monica FallonInstituto Hospital del Mar de Investigaciones Médicas (IMIM); Universidad Autónoma de Barcelona.
Francesc CotsServei d'Estudies, Parc de Salut Mar.
María A SebastianCentro de Atención Primaria Larrard, Barcelona, Spain.
Antonio Morilla-GrasaGlaucoma Department, Instituto Catalán de Retina (ICR).
Sergi MojalInstituto Hospital del Mar de Investigaciones Médicas (IMIM).
Xavier CastellsServei d'Estudies, Parc de Salut Mar.
Hospital Del Mar · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo analyze the cost and detection rate of a screening program for detecting glaucoma with imaging devices. MATERIALS AND

methodsIn this cross-sectional study, a glaucoma screening program was applied in a population-based sample randomly selected from a population of 23,527. Screening targeted the population at risk of glaucoma. Examinations included optic disk tomography (Heidelberg retina tomograph [HRT]), nerve fiber analysis, and tonometry. Subjects who met at least 2 of 3 endpoints (HRT outside normal limits, nerve fiber index ≥30, or tonometry ≥21 mmHg) were referred for glaucoma consultation. The currently established ("conventional") detection method was evaluated by recording data from primary care and ophthalmic consultations in the same population. The direct costs of screening and conventional detection were calculated by adding the unit costs generated during the diagnostic process. The detection rate of new glaucoma cases was assessed.

resultsThe screening program evaluated 414 subjects; 32 cases were referred for glaucoma consultation, 7 had glaucoma, and 10 had probable glaucoma. The current detection method assessed 677 glaucoma suspects in the population, of whom 29 were diagnosed with glaucoma or probable glaucoma. Glaucoma screening and the conventional detection method had detection rates of 4.1% and 3.1%, respectively, and the cost per case detected was 1,410 and 1,435€, respectively. The cost of screening 1 million inhabitants would be 5.1 million euros and would allow the detection of 4,715 new cases.

conclusionThe proposed screening method directed at population at risk allows a detection rate of 4.1% and a cost of 1,410 per case detected.

Indexed as

costdetection rateglaucomaimaging devicesscreening

Identifiers

PMID28243057
PMCPMC5317344
OpenAlexW2588343237

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.